F2RL1 and breast carcinoma: In a recent study, Paul et al., for the first time, showed that the TF/FVIIa-dependent activation of PAR2 triggers the immune evasion of breast cancer via the induction of programmed death-ligand 1 (PD-L1) expression and its stability [136].